| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |